Amalgamated Bank’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45K | Buy |
+10,798
| New | +$41K | ﹤0.01% | 1624 |
|
|
2026
Q1 | – | Sell |
-9,661
| Closed | -$26K | – | 2216 |
|
|
2025
Q4 | $26K | Buy |
9,661
+151
| +2% | +$349 | ﹤0.01% | 2013 |
|
|
2025
Q3 | $21K | Hold |
9,510
| – | – | ﹤0.01% | 2097 |
|
|
2025
Q2 | $16K | Hold |
9,510
| – | – | ﹤0.01% | 2204 |
|
|
2025
Q1 | $32K | Buy |
9,510
+1,179
| +14% | +$6.08K | ﹤0.01% | 1914 |
|
|
2024
Q4 | $62K | Hold |
8,331
| – | – | ﹤0.01% | 1789 |
|
|
2024
Q3 | $78K | Hold |
8,331
| – | – | ﹤0.01% | 1747 |
|
|
2024
Q2 | $67K | Buy |
8,331
+263
| +3% | +$2.82K | ﹤0.01% | 1799 |
|
|
2024
Q1 | $120K | Sell |
8,068
-12,868
| -61% | -$150K | ﹤0.01% | 1694 |
|
|
2023
Q4 | $170K | Sell |
20,936
-1,370
| -6% | -$7.17K | ﹤0.01% | 1844 |
|
|
2023
Q3 | $101K | Buy |
22,306
+4,434
| +25% | +$28.9K | ﹤0.01% | 1993 |
|
|
2023
Q2 | $126K | Buy |
17,872
+2,321
| +15% | +$16.6K | ﹤0.01% | 1988 |
|
|
2023
Q1 | $95K | Sell |
15,551
-3,682
| -19% | -$25.4K | ﹤0.01% | 2076 |
|
|
2022
Q4 | $123K | Hold |
19,233
| – | – | ﹤0.01% | 2051 |
|
|
2022
Q3 | $184K | Buy |
19,233
+187
| +1% | +$2.16K | ﹤0.01% | 1884 |
|
|
2022
Q2 | $210K | Sell |
19,046
-9,801
| -34% | -$128K | ﹤0.01% | 1857 |
|
|
2022
Q1 | $480K | Buy |
28,847
+633
| +2% | +$9.79K | ﹤0.01% | 1560 |
|
|
2021
Q4 | $539K | Buy |
28,214
+1,514
| +6% | +$33.3K | ﹤0.01% | 1543 |
|
|
2021
Q3 | $658K | Sell |
26,700
-1,090
| -4% | -$25.7K | 0.01% | 1448 |
|
|
2021
Q2 | $723K | Buy |
27,790
+2,158
| +8% | +$56.1K | 0.01% | 1445 |
|
|
2021
Q1 | $812K | Sell |
25,632
-2,234
| -8% | -$92.6K | 0.03% | 698 |
|
|
2020
Q4 | $1.29M | Sell |
27,866
-6
| -0% | -$238 | 0.05% | 400 |
|
|
2020
Q3 | $918K | Sell |
27,872
-178
| -0.6% | -$5.46K | 0.04% | 489 |
|
|
2020
Q2 | $770K | Buy |
28,050
+6,950
| +33% | +$228K | 0.04% | 552 |
|
|
2020
Q1 | $632K | Sell |
21,100
-934
| -4% | -$24.8K | 0.02% | 807 |
|
|
2019
Q4 | $610K | Buy |
22,034
+1,737
| +9% | +$39.5K | 0.01% | 1021 |
|
|
2019
Q3 | $369K | Sell |
20,297
-262
| -1% | -$5.79K | 0.01% | 1194 |
|
|
2019
Q2 | $504K | Buy |
20,559
+5,294
| +35% | +$79.7K | 0.01% | 1070 |
|
|
2019
Q1 | $145K | Buy |
15,265
+631
| +4% | +$6.13K | ﹤0.01% | 1564 |
|
|
2018
Q4 | $130K | Buy |
+14,634
| New | +$141K | ﹤0.01% | 1487 |
|
|
2018
Q3 | – | Sell |
-12,579
| Closed | -$161K | – | 1532 |
|
|
2018
Q2 | $161K | Buy |
+12,579
| New | +$184K | ﹤0.01% | 1609 |
|
Other funds holding IOVA
MFM
PAI
Amalgamated Bank's IOVA Position: Q2 2026 in Review
Amalgamated Bank opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 10,798 shares worth $45K. The stake represents ﹤0.01% of the portfolio and ranks #1624 among its holdings. This is a return to the name: Amalgamated Bank previously reported a position in IOVA as recently as Q4 2025.
Amalgamated Bank first reported a position in IOVA in Q2 2018 and has held it in 31 quarters since. The position peaked at $1.29M in Q4 2020. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.
- Amalgamated Bank held 10,798 shares of Iovance Biotherapeutics worth $45K as of Q2 2026.
- Iovance Biotherapeutics was a new Amalgamated Bank position in Q2 2026.
- Iovance Biotherapeutics made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1624 holding.
- Amalgamated Bank first reported a position in Iovance Biotherapeutics in Q2 2018 and has held it in 31 quarters since.
- Amalgamated Bank's Iovance Biotherapeutics position peaked at $1.29M in Q4 2020.
- 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.